Home » News Events » LACunar Intervention Trial-2 (LACI-2) featured in one of the leading Scottish newspapers - "The Scotsman"

LACunar Intervention Trial-2 (LACI-2) was featured in one of the leading scottish newspapers "The Scotsman". The study aims to assess safety and efficacy of inexpensive and widely accessible medication: cilostazol and isosorbide mononitrate to prevent recurrent lacunar stroke and progression of cerebral small vessel disease.  The research suggests that lacunar lesions could also be the underlying cause of nearly half of all dementias.

The study is funded by the British Heart Foundation and lead by Professor Joanna Wardlaw.

The study re-assumed recruiting participants after the break caused by the COVID-19 pandemic. Please, get in touch using the button below if you would like to participate in the study.

SVDs@ed.ac.uk

 

Read the article in "The Scotsman"

Article about LACunar Intervention Trial-2 (LACI-2) in "The Scotsman"

 

Related links

LACunar Intervention Trial-2 (LACI-2) website

Professor Joanna Wardlaw profile

Small Vessel Disease Research - publications

The University of Edinburgh Research team